{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:46:17Z","timestamp":1792431977782,"version":"4.5.0"},"reference-count":53,"publisher":"Scientific Scholar","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol Venereol Leprol"],"published-print":{"date-parts":[[2010]]},"DOI":"10.4103\/0378-6323.62961","type":"journal-article","created":{"date-parts":[[2010,5,4]],"date-time":"2010-05-04T07:56:19Z","timestamp":1272959779000},"page":"231","source":"Crossref","is-referenced-by-count":43,"title":["Topical treatment in vitiligo and the potential uses of new drug delivery systems"],"prefix":"10.25259","volume":"76","author":[{"given":"OmPrakash","family":"Katare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BhawnaJain","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abir","family":"Saraswat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0378-6323.62961-1","first-page":"41","volume-title":"Vitiligo and emotions","author":"Nogueira","year":"2009","journal-title":"An Bras Dermatol"},{"key":"key-10.4103\/0378-6323.62961-2","first-page":"149","volume-title":"Vitiligo: Compendium of clinicoepidemiological features","author":"Sehgal","year":"2007","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.62961-3","unstructured":"Satish DA, Walia A. Epidemiology and etiopathogenesis. In: Saraf V, Fernandez R, Sarangi K, editors. Vitiligo. 1 st ed. Mumbai: Fulford India Ltd; 2000. p. 18-22."},{"key":"key-10.4103\/0378-6323.62961-4","first-page":"22","volume-title":"Clinical study of vitiligo:Comparative study of type A and B vitiligo","author":"Song","year":"1994","journal-title":"Ann Dermatol"},{"key":"key-10.4103\/0378-6323.62961-5","first-page":"167","volume-title":"Vitiligo: Pathogenesis and treatment","author":"Njoo","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"key-10.4103\/0378-6323.62961-6","first-page":"1051","volume-title":"Guideline for the diagnosis and management of vitiligo","author":"Gawkrodger","year":"2008","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.62961-7","first-page":"110","volume-title":"Vitiligo: new and emerging treatments","author":"Lotti","year":"2008","journal-title":"Dermatol Ther"},{"key":"key-10.4103\/0378-6323.62961-8","first-page":"135","volume-title":"Choosing topical corticosteroids","author":"Ference","year":"2009","journal-title":"Am Fam Physician"},{"key":"key-10.4103\/0378-6323.62961-9","doi-asserted-by":"crossref","unstructured":"Sanclemente G, Garcia JJ, Zuleta JJ, Diehl C, Correa C, Falabella R. A double-blind, randomized trial of 0.05% betamethasone vs. topical catalase\/dismutase superoxide in vitiligo. J Eur Acad Dermatol Venereol 2008;22:1359-64.","DOI":"10.1111\/j.1468-3083.2008.02839.x"},{"key":"key-10.4103\/0378-6323.62961-10","first-page":"298","volume-title":"Comparison of two diluents of 1% methoxsalen in the treatment of vitiligo","author":"Godse","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.62961-11","first-page":"1022","volume-title":"Phototherapy with UV-B in vitiligo","author":"K\u03c6ster","year":"1990","journal-title":"Z Hautkr"},{"key":"key-10.4103\/0378-6323.62961-12","first-page":"9","volume-title":"Narrowband UVB phototherapy in vitiligo: evaluation of results in 53 patients","author":"Percivalle","year":"2008","journal-title":"G Ital Dermatol Venereol"},{"key":"key-10.4103\/0378-6323.62961-13","first-page":"174","volume-title":"Treatment of vitiligo with narrow-band ultraviolet B: advantages and disadvantages","author":"Abdulla","year":"2008","journal-title":"J Cutan Med Surg"},{"key":"key-10.4103\/0378-6323.62961-14","first-page":"409","volume-title":"Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo","author":"Rodr\u03bdguez-Mart\u03bdn","year":"2009","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.62961-15","first-page":"514","volume-title":"New insights on therapy with vitamin D analogs targeting the intracellular pathways that control repigmentation in human vitiligo","author":"Birlea","year":"2009","journal-title":"Med Res Rev"},{"key":"key-10.4103\/0378-6323.62961-16","first-page":"S13","volume-title":"Mechanism of vitamin D action and its regulation","author":"Dusso","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/0378-6323.62961-17","first-page":"55","volume-title":"Topical pimecrolimus in the treatment of vitiligo","author":"Boone","year":"2007","journal-title":"Eur J Dermatol"},{"key":"key-10.4103\/0378-6323.62961-18","first-page":"789","volume-title":"Topical tacrolimus for repigmentation of vitiligo","author":"Grimes","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.62961-19","first-page":"397","volume-title":"Characterization of the influence of some cyclodextrins on the stratum corneum from the hairless mouse","author":"Bentley","year":"1997","journal-title":"J Pharm Pharmacol"},{"key":"key-10.4103\/0378-6323.62961-20","first-page":"286","volume-title":"The efficacy of pimecrolimus 1% cream combined with microdermabrasion in the treatment of nonsegmental childhood vitiligo: a randomized placebo-controlled study","author":"Farajzadeh","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"key-10.4103\/0378-6323.62961-21","first-page":"647","volume-title":"Vitiligo","author":"Kovacs","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.62961-22","first-page":"760","volume-title":"Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser","author":"Njoo","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.62961-23","first-page":"90","volume-title":"Camouflage for vitiligo","author":"Tanioka","year":"2009","journal-title":"Dermatol Ther"},{"key":"key-10.4103\/0378-6323.62961-24","first-page":"23","volume-title":"Camouflaging vitiligo with dihydroxyacetone","author":"Hsu","year":"2008","journal-title":"Dermatol Online J"},{"key":"key-10.4103\/0378-6323.62961-25","first-page":"402","volume-title":"Dihydroxyacetone: a safe camouflaging option in vitiligo","author":"Rajatanavin","year":"2008","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0378-6323.62961-26","first-page":"74","volume-title":"Topical drug delivery: needs, theory and practice","author":"Idson","year":"1981","journal-title":"Pharm Tech"},{"key":"key-10.4103\/0378-6323.62961-27","first-page":"72","volume-title":"Modulation of the barrier function of the skin","author":"Hadgraft","year":"2001","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"key":"key-10.4103\/0378-6323.62961-28","first-page":"874","volume-title":"Targeted drug delivery to the skin and deeper tissues: role of physiology, solute structure and disease","author":"Roberts","year":"1997","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"key-10.4103\/0378-6323.62961-29","first-page":"121","volume-title":"Treatment of vitiligo with psoralen","author":"Kar","year":"1990","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.62961-30","first-page":"461","volume-title":"Vitiligo: A retrospective comparative analysis of treatment modalities in 500 patients","author":"Handa","year":"2001","journal-title":"J Dermatol"},{"key":"key-10.4103\/0378-6323.62961-31","first-page":"81","volume-title":"Physical enhancement of transdermal drug application: is delivery technology keeping up with pharmaceutical development?","author":"Cross","year":"2004","journal-title":"Curr Drug Deliv"},{"key":"key-10.4103\/0378-6323.62961-32","first-page":"2","volume-title":"Novel drug delivery systems: Potential in improving topical delivery of antiacne agents","author":"Date","year":"2006","journal-title":"Skin Pharmacol Physiol"},{"key":"key-10.4103\/0378-6323.62961-33","first-page":"608","volume-title":"Novel lipid-based colloidal dispersions as potential drug administration systems - expectations and reality","author":"Westesen","year":"2000","journal-title":"Colloid Polym Sci"},{"key":"key-10.4103\/0378-6323.62961-34","first-page":"675","volume-title":"Lipid vesicles and other colloids as drug carriers on the skin","author":"Cevc","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"key-10.4103\/0378-6323.62961-35","first-page":"165","volume-title":"Evaluation of novel soya-lecithin formulations for dermal use containing ketoprofen as a model drug","author":"Valenta","year":"2000","journal-title":"J Control Release"},{"key":"key-10.4103\/0378-6323.62961-36","first-page":"1029","volume-title":"Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg\/m2","author":"Safra","year":"2000","journal-title":"Ann Oncol"},{"key":"key-10.4103\/0378-6323.62961-37","first-page":"115","volume-title":"Cutaneous delivery of 8-methoxypsoralen from liposomal and niosomal carriers","author":"Sinico","year":"2006","journal-title":"J Drug Deliv Sci Technol"},{"key":"key-10.4103\/0378-6323.62961-38","first-page":"40","volume-title":"A randomized, double-blind, vehicle-controlled study of a novel liposomal dithranol formulation in psoriasis","author":"Saraswat","year":"2007","journal-title":"J Dermatolog Treat"},{"key":"key-10.4103\/0378-6323.62961-39","first-page":"423","volume-title":"Phycocyanin liposomes for topical anti-inflammatory activity: in-vitro in-vivo studies","author":"Manconia","year":"2009","journal-title":"J Pharm Pharmacol"},{"key":"key-10.4103\/0378-6323.62961-40","doi-asserted-by":"crossref","unstructured":"Jain B, Singh B, Katare OP, Vyas SP. Development and characterization of minoxidil-loaded liposomal system for delivery to pilosebaceous units. J Liposome Res 2009 in press.","DOI":"10.1080\/08982100903161449"},{"key":"key-10.4103\/0378-6323.62961-41","first-page":"54","volume-title":"Elastic liposomal formulation for sustained delivery of colchicine: in vitro characterization and in vivo evaluation of anti-gout activity","author":"Singh","year":"2009","journal-title":"AAPS J"},{"key":"key-10.4103\/0378-6323.62961-42","first-page":"61","volume-title":"Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage","author":"Cevc","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"key-10.4103\/0378-6323.62961-43","first-page":"11","volume-title":"Improved risk-benefit ratio for topical triamcinolone acetonide in transfersome in comparison with equipotent cream and ointment: a randomized controlled trial","author":"Fesq","year":"2003","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.62961-44","first-page":"144","volume-title":"Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy","author":"Fang","year":"2008","journal-title":"Int J Pharm"},{"key":"key-10.4103\/0378-6323.62961-45","first-page":"860","volume-title":"In vitro percutaneous permeation and skin accumulation of finasteride using vesicular ethosomal carriers","author":"Rao","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"key-10.4103\/0378-6323.62961-46","first-page":"1","volume-title":"Effect of preparation technique on the properties and in vivo efficacy of benzocaine-loaded ethosomes","author":"Maestrelli","year":"2009","journal-title":"J Liposome Res"},{"key":"key-10.4103\/0378-6323.62961-47","first-page":"18","volume-title":"Effect of the composition of lecithin\/n-propanol\/isopropyl myristate\/water microemulsions on barrier properties of mice skin for transdermal permeation of tetracaine hydrochloride: in vitro","author":"Changez","year":"2006","journal-title":"Colloids Surf B Biointerfaces"},{"key":"key-10.4103\/0378-6323.62961-48","first-page":"97","volume-title":"Lipid nano\/submicron emulsions as vehicles for topical flurbiprofen delivery","author":"Fang","year":"2004","journal-title":"Drug Deliv"},{"key":"key-10.4103\/0378-6323.62961-49","first-page":"427","volume-title":"A study of microemulsion systems for transdermal delivery of triptolide","author":"Chen","year":"2004","journal-title":"J Control Release"},{"key":"key-10.4103\/0378-6323.62961-50","first-page":"3000","volume-title":"Gelatin-stabilised microemulsion-based organogels facilitates percutaneous penetration of cyclosporin A in vitro and dermal pharmacokinetics in vivo","author":"Liu","year":"2007","journal-title":"J Pharm Sci"},{"key":"key-10.4103\/0378-6323.62961-51","first-page":"417","volume-title":"Topical delivery of aceclofenac from lecithin organogels: preformulation study","author":"Shaikh","year":"2006","journal-title":"Curr Drug Deliv"},{"key":"key-10.4103\/0378-6323.62961-52","first-page":"289","volume-title":"Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery","author":"Bhalekar","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"key-10.4103\/0378-6323.62961-53","first-page":"296","volume-title":"Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting","author":"Chen","year":"2006","journal-title":"J Control Release"}],"container-title":["Indian Journal of Dermatology, Venereology, and Leprology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T00:45:05Z","timestamp":1612658705000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijdvl.com\/topical-treatment-in-vitiligo-and-the-potential-uses-of-new-drug-delivery-systems\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"alternative-id":["62961"],"URL":"https:\/\/doi.org\/10.4103\/0378-6323.62961","relation":{},"ISSN":["0378-6323"],"issn-type":[{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}